---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-258932"
form_type: "8-K"
ticker: "CNTA"
cik: "0001847903"
company_name: "Centessa Pharmaceuticals plc"
filed_at: "2022-10-06T23:59:59+00:00"
generated_at: "2026-06-23T05:10:35.094180+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Centessa files corrected Articles of Association; no change to share structure or rights

## Summary
- Corrected Articles of Association adopted May 2021, effective June 2021, filed with UK Registrar.
- Articles authorize issuance of unlimited ordinary shares and unlimited deferred shares.
- Filing is procedural; no impact on business operations or financial results.

## SEC filing metadata
- accession: 0001193125-22-258932
- form_type: 8-K
- ticker: CNTA
- cik: 0001847903
- company_name: Centessa Pharmaceuticals plc
- filed_at: 2022-10-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1847903/000119312522258932/0001193125-22-258932-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1847903/000119312522258932/d378676d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-258932
- JSON: https://secwatch.observer/filing/0001193125-22-258932.json
- Plain text: https://secwatch.observer/filing/0001193125-22-258932.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.